Novo Nordisk, Eli Lilly and the GLP-1 economy
Unhedged
00:00
The Cultural Shift of GLP-1 Medications
This chapter explores the societal impacts of GLP-1 medications on fitness and weight loss perceptions, as well as shifts in consumer behavior among shoppers and retail leaders. It also analyzes the economics of these drugs, including their high costs, implications for insurance coverage, and insights from the Congressional Budget Office on their cost-effectiveness.
Transcript
Play full episode
